Topic

Jonathan Rowe, PhD, MS, MA, has worked in the pharmaceutical industry across clinical, quality and corporate teams for over 25 years. He currently leads ZS’s clinical development quality, operations and risk management functions from the New York office.

Articles

Optimizing feasibility through increased data collection.

Towards Data-Driven Clinical Trial Planning and Strategy

Similar to a world-class symphony, a curated site start-up model can accentuate its individual components and lead to swift starts for clinical trials.

Orchestrating Different Levels of a Successful Clinical Study Start-Up

Sujay Jadhav, global vice president, study start-up, Oracle Health Sciences, spoke with ACT on how study start-up has been impacted by the pandemic and what its future holds beyond COVID.

COVID-19 Puts Spotlight on Study Start-up

With a major wave of post-COVID trial starts on the horizon, the industry’s need to accelerate clinical research through study start-up is intensifying.

Fast Tracking Study Start-Up from Site Selection to First-Patient Enrollment 

Bayesian methods bring flexibility and speed to clinical trial design and analysis, and with increased access to the necessary computational power, are transforming today’s clinical research.

Employing the Power of Bayesian Methods to Expedite Learning

Why? Because more often than not, you do not want to accrue only one participant to a clinical trial.

One IS the Loneliest Number

Despite the substantial difficulties associated with orphan drug trial recruitment, this segment of the drug development market is booming.